MedTrace Logo

ReNu™ vs. Corticosteroids for the Treatment of Plantar Fasciitis

NCT02982226 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 150

Last updated 2020-04-21

No results posted yet for this study

Summary

The objective of this clinical trial is to evaluate both the safety and efficacy of the ReNu™ injection on pain and inflammation in subjects diagnosed with plantar fasciitis as compared to a Corticosteroid Injection which is considered standard of care.

Conditions

  • Fasciitis, Plantar

Interventions

OTHER

ReNu Injection

ReNu is an allograft tissue composed of particularized amniotic membrane and cell from the amniotic fluid.

OTHER

Corticosteroid Injection

Corticosteroids are considered a standard of care for treatment of Plantar Fasciitis

Sponsors & Collaborators

  • MileStone Research Organization

    collaborator INDUSTRY

  • Organogenesis

    collaborator INDUSTRY

  • NuTech Medical, Inc

    lead INDUSTRY

Principal Investigators

  • Alan Ng, DPM, FACFAS · Advanced Orthopedics

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-09-30
Primary Completion
2021-04-30
Completion
2021-04-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02982226 on ClinicalTrials.gov